Signalling: STATs: transcriptional control and biological impact
By D. Levy, James E. Darnell. Nature reviews. Molecular cell biology, 2002
3,246 citations recorded by the source corpus.
Subfields: Immunology, Molecular Biology, Oncology
View Paper: https://www.semanticscholar.org/paper/ce954fa3ae78c87ebd46d4c7536aabd2b6df0b5b
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Immunology
In Molecular Biology
In Oncology
Citations in the corpus
- Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer (2009, background): “Other STAT3 partners include androgen receptor, C/EBP, STAT6, STAT1, c-Jun, and β-catenin (63).”
- gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. (2009, background): “Persistent and aberrant activation of various members of the signal transducer and activator of transcription (STAT) family is a recurrent and unifying molecular feature of many human malignancies of hematological and epithelial origin (Levy and Darnell, 2002; Yu and Jove, 2004).”
- The molecular control of corpus luteum formation, function, and regression. (2007, background): “A single nucleotide difference between Stat5 response elements located on the ER and ER promoters is responsible for the observation that either Stat5a or Stat5b can stimulate ER transcription, whereas only Stat5b can activate transcription of ER (83).”
- STAT3 signaling in immunity (2016, background): “signaling mechanisms and functions in the early days of the field [37–42].”